It has been established that NSCLC patients who smoke have a higher chance of Kras mutation than those who do not smoke,36 and Kras mutation is known to be associated with MTHFD2 expression via MYC transcriptional regulation.14, 37, 38. The gene discussed is MTHFD2; the disease is non-small cell lung carcinoma.